A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Status
- RECRUITING
- Phase
- PHASE2
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)
- Status
- RECRUITING
- Phase
- PHASE3
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2